FOLH1 and neoplasm: We have therefore investigated the effects of PSMA-617 in PSMA-positive PCa cells, (LNCaP cells, lymph node carcinoma of the prostate) on binding of 177Lu-PSMA-617 to PSMA, tumour growth, cell-cycle arrest, cell death and the corresponding underlying mechanisms.